This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Lithium Therapy for Corticosteroid-Induced Mood Disorder

Takeshi Terao

Published: January 1, 2001

Article Abstract

Letter to the Editor

Sir: I read with interest the article by Wada et al., which investigated clinical characteristics and treatment of 9 cases of corticosteroid-induced mood disorder. I would like to comment on their pharmacotherapy as follows.
First, Wada et al. claimed that lithium should be carefully avoided because quite a few diseases treated with corticosteroids, such as nephrotic syndromes or systemic lupus erythematosus (SLE), provoke renal dysfunction. I cannot agree with their claim: I have treated 4 cases of steroid-induced depression in which lithium was remarkably effective and no severe side effects occurred.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Bipolar Disorder , Mood Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...